medigraphic.com
SPANISH

Revista Médica del Hospital General de México

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

1999, Number 4

<< Back Next >>

Rev Med Hosp Gen Mex 1999; 62 (4)

Magnesium sulphate in the inhibition of fasciculacions produced by succynilcholine

Estrada-Gutiérrez A, Leyva-Ramírez M, López-Herranz P
Full text How to cite this article

Language: Spanish
References: 12
Page: 251-254
PDF size: 82.71 Kb.


Key words:

Neuromuscular relaxant, succynilcholine, magnesium sulfate.

ABSTRACT

Objective: To determine if magnesium sulfate (Mg+SO4) inhibits the fasciculations induced by succynilcholine. Material and methods: It was done a blind prospective, longitudinal and double study. Men and women were included from 18 to 50 years of age, scheduled for surgery under general anesthesia. Patients received some type of antiacid with magnesium and those with diagnosis of acute or chronic renal failure were excluded. We formed two groups in aleatory form. In the group 1, saline solution 0.9% was administered (500 mL), thirty minutes before beginning the induction of anesthesia. In group 2, it was added magnesium sulfate (2 g) to the i.v. the saline solution 0.9%. In both groups we administered succynilcholine (Anectine) in dose of 1 mg/kg in one minute as muscular relaxant for orotracheal intubation. Results: We studied a total of 122 patients which 61 (50%) belonged to group 1 and 61 (50%) to group 2. Sex and age variables, had no significant statistically differences in none groups. In group 1, fifty patients (81%) had fasciculations and 11 (19%) didn’t present them, while in group 2, fourteen patients (22%) presented fasciculations and 47 (77%) didn’t fasciculate, giving a statistical signification (p ‹ 0.05). Conclusions: The Mg+SO4 inhibit the fasciculations produced by succynilcholine in a high percentage of the cases.


REFERENCES

  1. Michael FM. Clinic use of magnesium infusions in anesthesia. Anesth Analg 1992; 74: 129-136.

  2. Ghoeneim MM. The interaction between magnesium and other neuromuscular blocking agents. Anesthesiology 1970; 32: 23-25.

  3. Morris RL, Giessecke AH. Potentiation of muscle relaxants by magnesium sulfate therapy in toxemia of pregnancy. South Medic J 1968; 61: 25.

  4. Aldrete JA, Zahler A, Aikawa JK. Prevention of succynilcholine induced hiperkalemia by sulfate of magnesium. Can Anesth Soc J 1970; 17: 477-484.

  5. John ET. Potassium and anesthesia. Can J Anest 1993; 40: 227-240.

  6. John KF. Magnesium suplementation during pregnancy. Am J Gynecol 1980; 161: 115-119.

  7. James MFM. Use of magnesium sulfate in anesthesia management of pheochromocytoma. Anesthesiology 1985; 62: 188-190.

  8. De Vore JS. Magnesium sulfate prevents, succynilcholine induced fasciculation in toxemic patients. Anesthesiology 1980; 52: 76-77.

  9. James MFM, Cork RC, Dennett JE. Succynilcholine pretreatment with magnesium sulfate. Anesth Analg 1986; 65: 373-376.

  10. Leonard L Firestone. Procedimientos de anestesia clínica del Massachusetts General Hospital. España: Salvat, 1991: 221-240.

  11. Hanstenn PD, Horn JL, Febirger LL. Drug interaction. 2nd ed. Philadelphia, 1990: 123-127.

  12. Robert N. Fluid and electrolyte metabolism. 5th ed. New York: McGraw-Hill, 1994: 373-392.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Hosp Gen Mex. 1999;62